Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitalists | 3 | 2012 | 21 | 0.750 |
Why?
|
| Organizations | 1 | 2017 | 16 | 0.620 |
Why?
|
| Organizational Culture | 1 | 2017 | 59 | 0.600 |
Why?
|
| Mindfulness | 1 | 2017 | 41 | 0.590 |
Why?
|
| Clostridium Infections | 2 | 2008 | 52 | 0.580 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 42 | 0.540 |
Why?
|
| Cross Infection | 2 | 2008 | 195 | 0.530 |
Why?
|
| Inpatients | 3 | 2012 | 208 | 0.510 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 503 | 0.470 |
Why?
|
| Health Care Costs | 1 | 2016 | 346 | 0.440 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 445 | 0.440 |
Why?
|
| Social Support | 2 | 2012 | 423 | 0.430 |
Why?
|
| Hospital Costs | 1 | 2012 | 117 | 0.390 |
Why?
|
| Length of Stay | 2 | 2012 | 780 | 0.380 |
Why?
|
| Medication Adherence | 2 | 2012 | 335 | 0.370 |
Why?
|
| Job Satisfaction | 1 | 2009 | 62 | 0.350 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 772 | 0.290 |
Why?
|
| Phenazopyridine | 1 | 2006 | 5 | 0.290 |
Why?
|
| Anemia, Hemolytic | 1 | 2006 | 37 | 0.290 |
Why?
|
| International Classification of Diseases | 1 | 2006 | 85 | 0.290 |
Why?
|
| Nonprescription Drugs | 1 | 2006 | 28 | 0.290 |
Why?
|
| Anesthetics, Local | 1 | 2006 | 83 | 0.270 |
Why?
|
| Physicians | 1 | 2009 | 324 | 0.270 |
Why?
|
| Pneumococcal Infections | 1 | 2006 | 30 | 0.270 |
Why?
|
| Immunization | 1 | 2006 | 86 | 0.270 |
Why?
|
| Pneumonia, Bacterial | 1 | 2005 | 19 | 0.270 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2004 | 4 | 0.250 |
Why?
|
| Interprofessional Relations | 2 | 2021 | 188 | 0.250 |
Why?
|
| Vaccination | 1 | 2006 | 182 | 0.250 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 73 | 0.240 |
Why?
|
| Acute Kidney Injury | 1 | 2006 | 232 | 0.230 |
Why?
|
| Hospitalization | 2 | 2016 | 977 | 0.200 |
Why?
|
| Humans | 16 | 2021 | 68525 | 0.160 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 2077 | 0.150 |
Why?
|
| Curriculum | 1 | 2021 | 575 | 0.140 |
Why?
|
| Certification | 1 | 2016 | 66 | 0.130 |
Why?
|
| Disease Management | 1 | 2016 | 248 | 0.120 |
Why?
|
| Hospitals | 1 | 2016 | 265 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2016 | 403 | 0.120 |
Why?
|
| Nutritional Support | 1 | 2012 | 22 | 0.110 |
Why?
|
| Nutrition Assessment | 1 | 2012 | 43 | 0.110 |
Why?
|
| Friends | 1 | 2012 | 33 | 0.110 |
Why?
|
| Malnutrition | 1 | 2012 | 28 | 0.110 |
Why?
|
| Patient Care Planning | 1 | 2012 | 108 | 0.110 |
Why?
|
| Pharmacists | 1 | 2012 | 125 | 0.100 |
Why?
|
| Medication Errors | 1 | 2012 | 116 | 0.100 |
Why?
|
| Emotions | 1 | 2012 | 244 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 170 | 0.100 |
Why?
|
| Family | 1 | 2012 | 293 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2008 | 7264 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2012 | 294 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 693 | 0.090 |
Why?
|
| Practice Management, Medical | 1 | 2009 | 24 | 0.090 |
Why?
|
| Professional Autonomy | 1 | 2009 | 24 | 0.090 |
Why?
|
| Medicine | 1 | 2009 | 51 | 0.090 |
Why?
|
| Income | 1 | 2009 | 165 | 0.080 |
Why?
|
| Workload | 1 | 2009 | 103 | 0.080 |
Why?
|
| South Carolina | 2 | 2006 | 2750 | 0.080 |
Why?
|
| United States | 3 | 2016 | 7335 | 0.080 |
Why?
|
| Metronidazole | 1 | 2008 | 28 | 0.080 |
Why?
|
| Vancomycin | 1 | 2008 | 60 | 0.080 |
Why?
|
| Patient Education as Topic | 2 | 2012 | 424 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2009 | 261 | 0.080 |
Why?
|
| Boston | 1 | 2006 | 35 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2008 | 291 | 0.070 |
Why?
|
| Aged | 3 | 2008 | 14842 | 0.070 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2006 | 8 | 0.070 |
Why?
|
| Pneumococcal Vaccines | 1 | 2006 | 30 | 0.070 |
Why?
|
| Sex Factors | 1 | 2009 | 1265 | 0.070 |
Why?
|
| Community-Acquired Infections | 1 | 2006 | 46 | 0.070 |
Why?
|
| Female | 5 | 2012 | 38015 | 0.070 |
Why?
|
| Male | 5 | 2012 | 37281 | 0.070 |
Why?
|
| Middle Aged | 4 | 2012 | 21119 | 0.070 |
Why?
|
| Hospital Charges | 1 | 2005 | 60 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2006 | 285 | 0.060 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2006 | 88 | 0.060 |
Why?
|
| Cost Savings | 1 | 2005 | 110 | 0.060 |
Why?
|
| Age Factors | 1 | 2009 | 1860 | 0.060 |
Why?
|
| Health Services Research | 1 | 2005 | 209 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2006 | 284 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 503 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1753 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2008 | 2356 | 0.050 |
Why?
|
| Incidence | 1 | 2006 | 1582 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 1026 | 0.050 |
Why?
|
| Educational Status | 1 | 2021 | 273 | 0.050 |
Why?
|
| Inhibins | 1 | 1999 | 6 | 0.040 |
Why?
|
| Receptors, Growth Factor | 1 | 1999 | 6 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 1851 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2021 | 235 | 0.040 |
Why?
|
| Rod Opsins | 1 | 1999 | 59 | 0.040 |
Why?
|
| Students | 1 | 2021 | 233 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2021 | 311 | 0.040 |
Why?
|
| Retina | 1 | 1999 | 252 | 0.040 |
Why?
|
| Leucine Zippers | 1 | 1996 | 10 | 0.040 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2016 | 4 | 0.040 |
Why?
|
| Rhodopsin | 1 | 1996 | 135 | 0.030 |
Why?
|
| Rod Cell Outer Segment | 1 | 1996 | 56 | 0.030 |
Why?
|
| Photoreceptor Cells | 1 | 1996 | 62 | 0.030 |
Why?
|
| Eye Proteins | 1 | 1996 | 160 | 0.030 |
Why?
|
| Self Care | 1 | 2016 | 252 | 0.030 |
Why?
|
| Refeeding Syndrome | 1 | 2012 | 5 | 0.030 |
Why?
|
| Chick Embryo | 3 | 1999 | 379 | 0.030 |
Why?
|
| Medication Reconciliation | 1 | 2012 | 18 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2012 | 39 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 1996 | 700 | 0.030 |
Why?
|
| Transcription Factors | 1 | 1996 | 753 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 2012 | 157 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2012 | 339 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2012 | 331 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 955 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 1999 | 2673 | 0.020 |
Why?
|
| Retinal Pigments | 2 | 1999 | 61 | 0.020 |
Why?
|
| Adult | 1 | 2005 | 21375 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 1999 | 1034 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5719 | 0.010 |
Why?
|
| Follistatin | 1 | 1999 | 5 | 0.010 |
Why?
|
| Activins | 1 | 1999 | 4 | 0.010 |
Why?
|
| Activin Receptors | 1 | 1999 | 9 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 201 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 541 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1999 | 238 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 328 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 95 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 43 | 0.010 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 1996 | 19 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1996 | 71 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 230 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 1174 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1996 | 114 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 901 | 0.010 |
Why?
|
| Autoradiography | 1 | 1996 | 94 | 0.010 |
Why?
|
| Rhodamines | 1 | 1996 | 27 | 0.010 |
Why?
|
| Lectins | 1 | 1996 | 81 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1996 | 49 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1996 | 196 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 475 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1996 | 102 | 0.010 |
Why?
|
| Animals | 3 | 1999 | 20877 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 1015 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1999 | 1663 | 0.010 |
Why?
|
| Transfection | 1 | 1996 | 782 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1996 | 191 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 1082 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 1446 | 0.010 |
Why?
|
| DNA | 1 | 1996 | 597 | 0.010 |
Why?
|
| Protein Binding | 1 | 1996 | 1027 | 0.010 |
Why?
|
| Biomarkers | 1 | 1999 | 1593 | 0.010 |
Why?
|
| Neurons | 1 | 1999 | 881 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1996 | 1293 | 0.010 |
Why?
|